These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23513399)

  • 21. Effects of estrogen and psychological stress on plasma homocysteine levels.
    Farag NH; Barshop BA; Mills PJ
    Fertil Steril; 2003 Feb; 79(2):256-60. PubMed ID: 12568831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress measured by carbonyl groups level in postmenopausal women after oral and transdermal hormone therapy.
    Polac I; Borowiecka M; Wilamowska A; Nowak P
    J Obstet Gynaecol Res; 2012 Sep; 38(9):1177-81. PubMed ID: 22540414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between hot flashes severity and oxidative stress among Mexican postmenopausal women: A cross-sectional study.
    Sánchez-Rodríguez MA; Zacarías-Flores M; Arronte-Rosales A; Mendoza-Núñez VM
    PLoS One; 2019; 14(9):e0214264. PubMed ID: 31550247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No effect of HRT on health-related quality of life in postmenopausal women with heart disease.
    Sherman AM; Shumaker SA; Sharp P; Reboussin DM; Kancler C; Walkup M; Herrington DM
    Minerva Ginecol; 2003 Dec; 55(6):511-7. PubMed ID: 14676740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
    Stark KD; Park EJ; Holub BJ
    Menopause; 2003; 10(5):448-55. PubMed ID: 14501607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome.
    Simon JA; Stevens RE; Ayres SA; Phelps KV
    Climacteric; 2001 Mar; 4(1):19-27. PubMed ID: 11379374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
    Toth MJ; Sites CK; Matthews DE
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women.
    Vogelvang TE; Leurs JR; van der Mooren MJ; Mijatovic V; Hendriks DF; Neele SJ; Netelenbos JC; Kenemans P
    Menopause; 2004; 11(1):110-5. PubMed ID: 14716191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome.
    Sánchez-Rodríguez MA; Zacarías-Flores M; Castrejón-Delgado L; Ruiz-Rodríguez AK; Mendoza-Núñez VM
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypoglycemic effects of soy isoflavones on postmenopausal women.
    Cheng SY; Shaw NS; Tsai KS; Chen CY
    J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen replacement reverses endothelial dysfunction in postmenopausal women.
    Bush DE; Jones CE; Bass KM; Walters GK; Bruza JM; Ouyang P
    Am J Med; 1998 Jun; 104(6):552-8. PubMed ID: 9674718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postmenopausal symptoms severity enhancement oxidative stress in women with metabolic syndrome].
    Zacarías-Flores M; Sánchez-Rodríguez MA; Correa-Muñoz E; Arronte-Rosales A; Mendoza-Núñez VM
    Ginecol Obstet Mex; 2014 Dec; 82(12):796-806. PubMed ID: 25826964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of daily blueberry consumption on circulating biomarkers of oxidative stress, inflammation, and antioxidant defense in postmenopausal women with pre- and stage 1-hypertension: a randomized controlled trial.
    Johnson SA; Feresin RG; Navaei N; Figueroa A; Elam ML; Akhavan NS; Hooshmand S; Pourafshar S; Payton ME; Arjmandi BH
    Food Funct; 2017 Jan; 8(1):372-380. PubMed ID: 28059417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal hormone therapy and quality of life.
    Smith AJ; Hall DR; Grové D
    Int J Gynaecol Obstet; 2006 Dec; 95(3):267-71. PubMed ID: 16919633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.